{
      "0": "shorten",
      "1": "risk of",
      "2": "calculated using",
      "3": "approved in",
      "4": "experience",
      "5": "database",
      "6": "pioneered by",
      "7": "chosen based on",
      "8": "clinical sign",
      "9": "persist after",
      "10": "promotes",
      "11": "fuels",
      "12": "generic name",
      "13": "do not",
      "14": "enforce",
      "15": "third generation",
      "16": "prescribed by",
      "17": "performed in",
      "18": "future research",
      "19": "has fewer",
      "20": "levels affected by",
      "21": "neurotoxic in",
      "22": "occur due to",
      "23": "\u6d89\u53ca",
      "24": "prescribe",
      "25": "managed via",
      "26": "seeps from",
      "27": "synthesized in",
      "28": "project to",
      "29": "published by",
      "30": "swelling",
      "31": "do not require",
      "32": "public health concern",
      "33": "encodes",
      "34": "minimized with",
      "35": "assessed through",
      "36": "classified by",
      "37": "digests",
      "38": "sometimes contain",
      "39": "novel delivery systems include",
      "40": "can lead",
      "41": "brand examples",
      "42": "may attenuate",
      "43": "impair",
      "44": "change during",
      "45": "restores",
      "46": "lead to",
      "47": "clearance",
      "48": "subtype",
      "49": "removed through",
      "50": "viscosity",
      "51": "balances",
      "52": "explains",
      "53": "\u4f5c\u4e3a",
      "54": "not studied in",
      "55": "shown to",
      "56": "identify",
      "57": "generic availability",
      "58": "more effective than",
      "59": "stored at",
      "60": "range from",
      "61": "\u614e\u7528\u4e8e",
      "62": "preferred in",
      "63": "hereditary in",
      "64": "generated in",
      "65": "specifically treat",
      "66": "decreases",
      "67": "enhances effects of",
      "68": "excreted via",
      "69": "ineffective against",
      "70": "use",
      "71": "may worsen with",
      "72": "may lack",
      "73": "selection criteria",
      "74": "are part of",
      "75": "designed in",
      "76": "crosses placenta",
      "77": "factor",
      "78": "convenient for",
      "79": "rarely given as",
      "80": "synergistic with",
      "81": "distributed in",
      "82": "a metric in",
      "83": "helps eliminate",
      "84": "monitored via",
      "85": "is hypersensitivity reaction to",
      "86": "should be used",
      "87": "can interact",
      "88": "staffed by",
      "89": "degrade over",
      "90": "mounted on",
      "91": "adjusted by",
      "92": "\u589e\u52a0",
      "93": "plays role in",
      "94": "risk increased by",
      "95": "advantages",
      "96": "prolongs",
      "97": "therapeutic use",
      "98": "reported by",
      "99": "has lower",
      "100": "recorded in",
      "101": "expiry date",
      "102": "diluted with",
      "103": "deficient in",
      "104": "aided by",
      "105": "is concern for",
      "106": "synthetic versions",
      "107": "treated for",
      "108": "may indicate",
      "109": "increased risk of",
      "110": "may induce",
      "111": "does not need",
      "112": "drawn before",
      "113": "replace",
      "114": "\u963b\u65ad",
      "115": "collect",
      "116": "assists",
      "117": "transmits",
      "118": "verified by",
      "119": "dries",
      "120": "decreases effect of",
      "121": "aligns",
      "122": "combines",
      "123": "site of action",
      "124": "monitors",
      "125": "categorizes",
      "126": "FDA black box warning",
      "127": "advises on",
      "128": "adhere to",
      "129": "damages",
      "130": "\u62ee\u6297",
      "131": "shown in",
      "132": "resistant to",
      "133": "overdose",
      "134": "works in",
      "135": "public health",
      "136": "may protect",
      "137": "are",
      "138": "provides",
      "139": "utilized by",
      "140": "participates in",
      "141": "decays into",
      "142": "should be taken",
      "143": "delivers",
      "144": "dosage form",
      "145": "prevalent in",
      "146": "not recommended in",
      "147": "method",
      "148": "more sensitive to",
      "149": "often safe in",
      "150": "confirms",
      "151": "finances",
      "152": "administered with",
      "153": "complications include",
      "154": "confused with",
      "155": "class",
      "156": "onset varies",
      "157": "high for",
      "158": "represses",
      "159": "variant of",
      "160": "close",
      "161": "publish",
      "162": "confer",
      "163": "do not modify",
      "164": "added to",
      "165": "sealed with",
      "166": "monitored for",
      "167": "solution appears",
      "168": "\u5e38\u89c1\u8bf1\u56e0",
      "169": "equipped with",
      "170": "diagnosis involves",
      "171": "\u9700\u8981",
      "172": "reviewed in",
      "173": "severity varies",
      "174": "manifestation",
      "175": "characteristic of",
      "176": "pharmacodynamics",
      "177": "\u83b7\u53d6",
      "178": "implies",
      "179": "recorded by",
      "180": "are essential for",
      "181": "antagonistic to",
      "182": "risk factor for",
      "183": "monitored by",
      "184": "can calm",
      "185": "granted by",
      "186": "read",
      "187": "informs",
      "188": "can develop",
      "189": "reverse",
      "190": "used before",
      "191": "categorized under",
      "192": "absorbed via",
      "193": "obtained through",
      "194": "bridge",
      "195": "compared to",
      "196": "\u91cd\u8981\u4e8e",
      "197": "expensive for",
      "198": "culminates in",
      "199": "are a class of",
      "200": "correlate with",
      "201": "indicated for",
      "202": "give",
      "203": "confirm",
      "204": "tailored to",
      "205": "respond better to",
      "206": "developed by",
      "207": "genetic forms involve",
      "208": "emitted by",
      "209": "oxidized in",
      "210": "peak in",
      "211": "effects",
      "212": "increases in",
      "213": "caused by",
      "214": "absorbed minimally",
      "215": "often comorbid with",
      "216": "focuses on",
      "217": "duration varies",
      "218": "enzyme",
      "219": "categorized as",
      "220": "can reduce",
      "221": "\u6d53\u5ea6\u53d6\u51b3\u4e8e",
      "222": "exacerbates",
      "223": "can result in",
      "224": "differs in",
      "225": "emerges",
      "226": "last for",
      "227": "quality control",
      "228": "prescribes",
      "229": "receptor selectivity",
      "230": "publishes",
      "231": "may absorb",
      "232": "sourced from",
      "233": "regulatory status",
      "234": "produces",
      "235": "are contraindicated in",
      "236": "are produced by",
      "237": "research field",
      "238": "parameter",
      "239": "popular among",
      "240": "cardiotoxicity",
      "241": "interpret",
      "242": "benefits",
      "243": "banned in",
      "244": "effect potentially enhanced by",
      "245": "eases",
      "246": "formulated with",
      "247": "lasts over",
      "248": "prompt",
      "249": "specialize in",
      "250": "dwell time",
      "251": "\u5c5e\u4e8e",
      "252": "\u8003\u8651\u7528\u4e8e",
      "253": "guide",
      "254": "function tests",
      "255": "exposed to",
      "256": "powered by",
      "257": "\u534a\u8870\u671f",
      "258": "binds to",
      "259": "recommended in",
      "260": "catalyze",
      "261": "difficult to",
      "262": "distributed through",
      "263": "integrate with",
      "264": "tracked using",
      "265": "loses",
      "266": "limited for",
      "267": "relieved with",
      "268": "is common",
      "269": "reduces",
      "270": "shows efficacy against",
      "271": "has",
      "272": "avoided by",
      "273": "patient education includes",
      "274": "organizes",
      "275": "should not be used with",
      "276": "fertilized by",
      "277": "grow in",
      "278": "caution with",
      "279": "help manage",
      "280": "regulated as",
      "281": "special population",
      "282": "encoded by",
      "283": "open",
      "284": "recalled for",
      "285": "scanned with",
      "286": "induce",
      "287": "made of",
      "288": "taken with",
      "289": "can affect",
      "290": "coverage",
      "291": "useful in",
      "292": "aid in",
      "293": "branch of",
      "294": "\u53ef\u80fd\u589e\u52a0",
      "295": "is enhanced by",
      "296": "alleviated by",
      "297": "risk for",
      "298": "altered in",
      "299": "classifies",
      "300": "also prevents",
      "301": "costlier than",
      "302": "metastasizes to",
      "303": "mature in",
      "304": "helps develop",
      "305": "additive effect with",
      "306": "\u7814\u53d1\u59cb\u4e8e",
      "307": "short-acting",
      "308": "safer for",
      "309": "aim to",
      "310": "mild",
      "311": "distinguishes",
      "312": "activated by",
      "313": "alternative in pregnancy",
      "314": "mark",
      "315": "recommend",
      "316": "evolve with",
      "317": "can have",
      "318": "occurs within",
      "319": "alternation recommended for",
      "320": "often include",
      "321": "also treats",
      "322": "crosses",
      "323": "send signals to",
      "324": "host",
      "325": "inhibit",
      "326": "black box warning for",
      "327": "harbor",
      "328": "often receive",
      "329": "kill",
      "330": "lacks",
      "331": "distorts",
      "332": "are alternatives to",
      "333": "hydrolyzes",
      "334": "face challenges in",
      "335": "supply",
      "336": "categorized by",
      "337": "example is",
      "338": "distributed to",
      "339": "is involved",
      "340": "broad-spectrum",
      "341": "performed with",
      "342": "signal",
      "343": "can be used with",
      "344": "\u5f71\u54cd",
      "345": "narrows",
      "346": "is crucial",
      "347": "administered",
      "348": "stimulated by",
      "349": "relax during",
      "350": "contribute to",
      "351": "carries risk",
      "352": "stimulates",
      "353": "must match",
      "354": "are regulated by",
      "355": "is sensitive",
      "356": "\u51cf\u8f7b",
      "357": "lack cross-reactivity with",
      "358": "lighten",
      "359": "is characterized by",
      "360": "integrates",
      "361": "inhibitor",
      "362": "filled with",
      "363": "can mask",
      "364": "side effects",
      "365": "treatment failure suggests",
      "366": "alternative for",
      "367": "\u5f15\u8d77",
      "368": "properties",
      "369": "useful for",
      "370": "recommended after",
      "371": "replaces",
      "372": "produced by",
      "373": "alternative to",
      "374": "affected in",
      "375": "deals with",
      "376": "is prevented",
      "377": "makes it",
      "378": "absorbs",
      "379": "paralyzes",
      "380": "lubricates",
      "381": "exists in",
      "382": "studied in",
      "383": "does not affect",
      "384": "decreases absorption of",
      "385": "\u6709",
      "386": "is risk factor for",
      "387": "is first-line for",
      "388": "interfere with",
      "389": "function in",
      "390": "draw",
      "391": "increased in",
      "392": "sometimes combined with",
      "393": "evade",
      "394": "for otologic drugs",
      "395": "often tested in",
      "396": "effectiveness depends on",
      "397": "efficacy",
      "398": "indicator for",
      "399": "dilates during",
      "400": "sometimes causes",
      "401": "excreted in",
      "402": "absorbed with",
      "403": "adapt for",
      "404": "reduces risk",
      "405": "counteracts",
      "406": "undergo",
      "407": "customize for",
      "408": "has subtype",
      "409": "varies by",
      "410": "may delay",
      "411": "prolonged by",
      "412": "indication",
      "413": "\u5206\u6790\u5305\u62ec",
      "414": "teaching point",
      "415": "manufacturing standards",
      "416": "introduced at",
      "417": "monitoring required",
      "418": "ripens",
      "419": "educational material",
      "420": "heals by",
      "421": "penetrate",
      "422": "more effective in",
      "423": "considers",
      "424": "used to treat",
      "425": "sold",
      "426": "spreads to",
      "427": "emphasize",
      "428": "preservative",
      "429": "increases susceptibility to",
      "430": "digested by",
      "431": "must meet",
      "432": "stored under",
      "433": "not effective against",
      "434": "relax",
      "435": "disturbs",
      "436": "can reverse",
      "437": "\u7597\u6548\u53d7",
      "438": "refresh",
      "439": "harmed by",
      "440": "neutralize",
      "441": "act against",
      "442": "can become",
      "443": "work by",
      "444": "seen in",
      "445": "mutations increase",
      "446": "target",
      "447": "white part",
      "448": "may inhibit",
      "449": "cost-effective",
      "450": "disrupts",
      "451": "\u68c0\u6d4b",
      "452": "peaks in",
      "453": "are measured in",
      "454": "first-generation includes",
      "455": "need more",
      "456": "are a",
      "457": "repaired with",
      "458": "at risk due to",
      "459": "analyzed via",
      "460": "impacts",
      "461": "\u7528\u4e8e\u8bc4\u4f30",
      "462": "often paired with",
      "463": "pollute",
      "464": "half-life",
      "465": "formulation affects",
      "466": "assessed",
      "467": "numb",
      "468": "storage requirement",
      "469": "route",
      "470": "spread by",
      "471": "\u6c34\u89e3",
      "472": "takes",
      "473": "subclass of",
      "474": "screens for",
      "475": "photosensitizing agents",
      "476": "originates in",
      "477": "delivered via",
      "478": "needed with",
      "479": "surveillance",
      "480": "may strengthen",
      "481": "post-marketing surveillance",
      "482": "irritates",
      "483": "detected by",
      "484": "contraindicates",
      "485": "strongly block",
      "486": "accumulates in",
      "487": "defined as",
      "488": "has half-life",
      "489": "mimics",
      "490": "are more",
      "491": "metabolizes to",
      "492": "application route",
      "493": "alternative in",
      "494": "potent",
      "495": "may be",
      "496": "drug holiday",
      "497": "reactivates",
      "498": "performed by",
      "499": "pediatric use",
      "500": "discontinuation",
      "501": "resistance mediated by",
      "502": "exposes",
      "503": "may mitigate",
      "504": "compliance issue",
      "505": "improved with",
      "506": "relaxation",
      "507": "treated by",
      "508": "molecular weight",
      "509": "a symptom of",
      "510": "includes",
      "511": "suppressed by",
      "512": "classification",
      "513": "easier to",
      "514": "mask symptoms of",
      "515": "break down into",
      "516": "confirmed by",
      "517": "approved by",
      "518": "pregnancy risk",
      "519": "excess causes",
      "520": "carries",
      "521": "adds benefits to",
      "522": "prepares",
      "523": "is stored in",
      "524": "target level",
      "525": "targeted by",
      "526": "based on",
      "527": "combine with",
      "528": "absorbs through",
      "529": "changes",
      "530": "transcribed from",
      "531": "common brand",
      "532": "endemic in",
      "533": "alternative administration",
      "534": "excipients",
      "535": "renal dose adjustment",
      "536": "subject to",
      "537": "face",
      "538": "innervates",
      "539": "mimic",
      "540": "\u6cbb\u7597",
      "541": "high doses can",
      "542": "active period of",
      "543": "important for",
      "544": "\u53ef\u7528\u4e8e",
      "545": "mitigates",
      "546": "secretion increases during",
      "547": "dilate",
      "548": "weighs about",
      "549": "accelerates",
      "550": "written by",
      "551": "result of",
      "552": "increases sensitivity to",
      "553": "FDA approval",
      "554": "advances through",
      "555": "limits",
      "556": "absorption",
      "557": "mortality rate",
      "558": "conserve",
      "559": "packaged in",
      "560": "is produced by",
      "561": "lasts",
      "562": "analyze",
      "563": "regulated by",
      "564": "examined by",
      "565": "selected by",
      "566": "pediatric dosing",
      "567": "source",
      "568": "not used in",
      "569": "popular in",
      "570": "nicknamed",
      "571": "pH level",
      "572": "beneficial for",
      "573": "deters",
      "574": "dispensed by",
      "575": "\u53ef\u80fd\u4ea7\u751f",
      "576": "now have",
      "577": "treats",
      "578": "controversial due",
      "579": "not absorbed",
      "580": "enables",
      "581": "tested in",
      "582": "secretes",
      "583": "may be affected by",
      "584": "connected to",
      "585": "can be used",
      "586": "may fail",
      "587": "visualize",
      "588": "become",
      "589": "shared by",
      "590": "placed in",
      "591": "affect",
      "592": "mediates",
      "593": "develop",
      "594": "strengthened by",
      "595": "raised by",
      "596": "related to",
      "597": "studied via",
      "598": "synthetic analog",
      "599": "transported by",
      "600": "insufficient for",
      "601": "contraindicated with",
      "602": "alternative form",
      "603": "do not block",
      "604": "described in",
      "605": "superior in",
      "606": "during",
      "607": "coordinated by",
      "608": "process",
      "609": "precursor to",
      "610": "overdose treatment",
      "611": "clears",
      "612": "effectiveness rate",
      "613": "adverse event reporting",
      "614": "receives blood from",
      "615": "create",
      "616": "can be treated with",
      "617": "DEA schedule",
      "618": "is complication of",
      "619": "required during",
      "620": "spread through",
      "621": "assessed by",
      "622": "modulated by",
      "623": "inactivated by",
      "624": "pharmacovigilance",
      "625": "comparative safety",
      "626": "\u7ec4\u5408",
      "627": "contraindicated",
      "628": "may help",
      "629": "repairs",
      "630": "orders",
      "631": "may improve",
      "632": "structural feature",
      "633": "degrades in",
      "634": "verifies",
      "635": "used post",
      "636": "resets",
      "637": "can worsen",
      "638": "contribute",
      "639": "overdose symptoms",
      "640": "prophylaxis",
      "641": "\u7814\u7a76",
      "642": "can be airborne",
      "643": "activation",
      "644": "act as",
      "645": "confers resistance to",
      "646": "acts as",
      "647": "is a risk of",
      "648": "sign of",
      "649": "recreational use",
      "650": "appears as",
      "651": "differ in",
      "652": "lactation",
      "653": "are less potent than",
      "654": "anti-androgenic effect",
      "655": "\u5173\u952e\u4e8e",
      "656": "triggers",
      "657": "outweighs",
      "658": "ablated by",
      "659": "depends on",
      "660": "synthesized from",
      "661": "concern with",
      "662": "combinations include",
      "663": "surpasses",
      "664": "inserted with",
      "665": "work with",
      "666": "don't treat",
      "667": "possesses",
      "668": "studied for",
      "669": "causes",
      "670": "disturb",
      "671": "\u7531",
      "672": "ongoing for",
      "673": "potential side effect",
      "674": "withdrawal syndrome",
      "675": "forms during",
      "676": "synergistic effect",
      "677": "advises",
      "678": "accelerated in",
      "679": "developed in",
      "680": "located above",
      "681": "spreads",
      "682": "stands for",
      "683": "occurs after",
      "684": "gives rise to",
      "685": "lines",
      "686": "neurohormonal effects",
      "687": "driven by",
      "688": "elevate",
      "689": "issues",
      "690": "sustains",
      "691": "propagate along",
      "692": "has analogue",
      "693": "expose patients to",
      "694": "\u7a7f\u8fc7",
      "695": "inhibited by",
      "696": "may benefit",
      "697": "mutation",
      "698": "insurance coverage",
      "699": "contains",
      "700": "transmitted by",
      "701": "success rate",
      "702": "kill microorganisms",
      "703": "common side effect of",
      "704": "commonly use",
      "705": "obtained from",
      "706": "used as",
      "707": "shown by",
      "708": "requires caution with",
      "709": "storage condition",
      "710": "interacts with",
      "711": "\u51b3\u5b9a",
      "712": "stores",
      "713": "checks for",
      "714": "secreted by",
      "715": "interferes with",
      "716": "interprets",
      "717": "discussed in",
      "718": "measurement units",
      "719": "may be from",
      "720": "verify",
      "721": "supplemented with",
      "722": "checks",
      "723": "lined with",
      "724": "adsorb",
      "725": "complicate",
      "726": "may relieve",
      "727": "involves",
      "728": "trial use",
      "729": "pediatric dose",
      "730": "more prone",
      "731": "burden",
      "732": "allocates",
      "733": "selected based on",
      "734": "modern use",
      "735": "reach",
      "736": "closes",
      "737": "preserve",
      "738": "discontinued after",
      "739": "screen",
      "740": "enzyme cofactor",
      "741": "sample size",
      "742": "builds",
      "743": "cannot reach",
      "744": "indication for",
      "745": "restrict",
      "746": "optimizes",
      "747": "newer than",
      "748": "correlates with",
      "749": "for",
      "750": "study",
      "751": "excreted by",
      "752": "help",
      "753": "may counteract",
      "754": "degrade in",
      "755": "reduce efficacy of",
      "756": "used",
      "757": "is managed with",
      "758": "prevention",
      "759": "used by",
      "760": "alternatives",
      "761": "may occur with",
      "762": "benefit from",
      "763": "differentiated by",
      "764": "manufacture",
      "765": "examines",
      "766": "often combined with",
      "767": "at higher risk for",
      "768": "can be monitored with",
      "769": "may turn positive during",
      "770": "filter",
      "771": "necessitate",
      "772": "aging populations drive",
      "773": "\u6539\u5584",
      "774": "fund",
      "775": "is an example of",
      "776": "can be occupational",
      "777": "maps",
      "778": "can slow",
      "779": "is protected",
      "780": "\u4e0d\u7a7f\u8fc7",
      "781": "pass through",
      "782": "may have",
      "783": "threshold",
      "784": "breakthrough",
      "785": "depleted in",
      "786": "varies among",
      "787": "\u901a\u8fc7",
      "788": "works by",
      "789": "act locally",
      "790": "absorption lower in",
      "791": "provide",
      "792": "determine",
      "793": "shown with",
      "794": "neutral on",
      "795": "first-line treatment for",
      "796": "collected by",
      "797": "vary among",
      "798": "facilitate",
      "799": "less effective than",
      "800": "occurs via",
      "801": "peaks",
      "802": "precede",
      "803": "resembles",
      "804": "educated on",
      "805": "saw",
      "806": "natural alternative",
      "807": "sheds during",
      "808": "delivered to",
      "809": "\u4f9d\u636e",
      "810": "stabilize",
      "811": "is a type of",
      "812": "analog of",
      "813": "is limited to",
      "814": "enhance",
      "815": "cleaves",
      "816": "loop type",
      "817": "relieves",
      "818": "induces",
      "819": "range",
      "820": "Nobel Prize",
      "821": "duration limited by",
      "822": "justify",
      "823": "dosage",
      "824": "rare but",
      "825": "risk",
      "826": "warrants",
      "827": "deteriorates with",
      "828": "surround",
      "829": "contraindicated in",
      "830": "measurement",
      "831": "reimburses",
      "832": "less cardiotoxic than",
      "833": "lifecycle",
      "834": "severe",
      "835": "can strengthen",
      "836": "brand name",
      "837": "influence",
      "838": "tolerance",
      "839": "manifest as",
      "840": "usually",
      "841": "transport patients",
      "842": "harbors",
      "843": "consideration",
      "844": "less likely to cause",
      "845": "emerge from",
      "846": "given during",
      "847": "may sense",
      "848": "primarily activates",
      "849": "presents with",
      "850": "symptom of",
      "851": "expand",
      "852": "combination therapy with",
      "853": "educate",
      "854": "features",
      "855": "prepared in",
      "856": "decreased by",
      "857": "administered by",
      "858": "absorbed",
      "859": "alternative therapies",
      "860": "occlusion increases",
      "861": "designed by",
      "862": "\u53d1\u5c55\u6210",
      "863": "\u6548\u679c\u53d6\u51b3\u4e8e",
      "864": "can displace",
      "865": "effectiveness measured by",
      "866": "rare in",
      "867": "may contain",
      "868": "clinical trials evaluate",
      "869": "replenished by",
      "870": "are monitored in",
      "871": "have higher risk",
      "872": "pregnancy category",
      "873": "replenishes",
      "874": "assessed with",
      "875": "rare side effect",
      "876": "mitigated by",
      "877": "palliates",
      "878": "have higher",
      "879": "measured with",
      "880": "absorption higher in",
      "881": "tested with",
      "882": "measured against",
      "883": "managed with",
      "884": "metabolized to",
      "885": "limited by",
      "886": "considered in",
      "887": "are administered via",
      "888": "thickens during",
      "889": "formulation",
      "890": "tested for",
      "891": "represents",
      "892": "receives",
      "893": "biocompatibility",
      "894": "often used in",
      "895": "ensures",
      "896": "is mitigated by",
      "897": "preserved by",
      "898": "combination therapy",
      "899": "elimination half-life",
      "900": "geriatric considerations",
      "901": "alternatives include",
      "902": "consequence",
      "903": "peak time varies by",
      "904": "safe for",
      "905": "impacted by",
      "906": "duration",
      "907": "works best",
      "908": "are prone",
      "909": "subtypes",
      "910": "used on",
      "911": "recommended for",
      "912": "patient education",
      "913": "forms",
      "914": "feature of",
      "915": "transitions to",
      "916": "follow",
      "917": "risk reduced by",
      "918": "decline with",
      "919": "often cause",
      "920": "\u964d\u4f4e\u4e8e",
      "921": "research ongoing",
      "922": "performs",
      "923": "dissolve",
      "924": "reported to",
      "925": "learns",
      "926": "often",
      "927": "varies in",
      "928": "frequency depends on",
      "929": "preceded by",
      "930": "absorb",
      "931": "links",
      "932": "inactivate",
      "933": "is branch of",
      "934": "non-pharmacological support",
      "935": "formulation includes",
      "936": "hinders",
      "937": "feature",
      "938": "non-dihydropyridines",
      "939": "is crucial for",
      "940": "performed on",
      "941": "adds",
      "942": "category",
      "943": "stabilizes",
      "944": "highly contagious",
      "945": "produced in",
      "946": "displays",
      "947": "tachyphylaxis develops with",
      "948": "impairs",
      "949": "primarily affects",
      "950": "exacerbate",
      "951": "lowered by",
      "952": "active metabolite",
      "953": "lactation risk",
      "954": "can be lowered by",
      "955": "oxygenate",
      "956": "absorption rate",
      "957": "preferred for",
      "958": "excreted as",
      "959": "reveals",
      "960": "can detect",
      "961": "\u4f18\u52bf",
      "962": "contraindication due to",
      "963": "addiction possible with",
      "964": "used during",
      "965": "connects",
      "966": "\u4f8b\u5982",
      "967": "prescribed cautiously in",
      "968": "implement",
      "969": "compared in",
      "970": "is supported by",
      "971": "may occur",
      "972": "documented in",
      "973": "is severe reaction to",
      "974": "personalized medicine",
      "975": "cost",
      "976": "are bactericidal",
      "977": "are calibrated by",
      "978": "pH affects",
      "979": "renal impairment",
      "980": "often feature",
      "981": "occurs with",
      "982": "\u63a8\u8350\u7ed9",
      "983": "highlights",
      "984": "more effective for",
      "985": "alternative surgery",
      "986": "absorbed into",
      "987": "repaired by",
      "988": "prepare",
      "989": "generate",
      "990": "fluctuate with",
      "991": "avoided with",
      "992": "unaffected by",
      "993": "\u63d0\u793a",
      "994": "relieved by",
      "995": "can treat",
      "996": "is banned in",
      "997": "is measured by",
      "998": "monitor glucose with",
      "999": "show higher cross-reactivity with",
      "1000": "optimized by",
      "1001": "lined by",
      "1002": "guidelines recommend",
      "1003": "can progress to",
      "1004": "basis",
      "1005": "synergize with",
      "1006": "helps diagnose",
      "1007": "can balance",
      "1008": "occurs around",
      "1009": "are based on",
      "1010": "adjust",
      "1011": "avoids",
      "1012": "slows",
      "1013": "\u53ef\u80fd\u964d\u4f4e",
      "1014": "can be tracked with",
      "1015": "flavor",
      "1016": "sensitive to",
      "1017": "dosing",
      "1018": "helps plan",
      "1019": "maintain",
      "1020": "administered in",
      "1021": "increases with",
      "1022": "should avoid",
      "1023": "reabsorbs",
      "1024": "older than",
      "1025": "reduces need for",
      "1026": "experienced in",
      "1027": "storage",
      "1028": "more potent than",
      "1029": "bind to",
      "1030": "\u6548\u679c\u53ef\u80fd",
      "1031": "discovery",
      "1032": "reversible with",
      "1033": "built through",
      "1034": "peak after",
      "1035": "allow",
      "1036": "in",
      "1037": "is derivative of",
      "1038": "excretes",
      "1039": "act",
      "1040": "are regulated as",
      "1041": "approved for",
      "1042": "screened through",
      "1043": "expires after",
      "1044": "binds",
      "1045": "packaging includes",
      "1046": "ordered by",
      "1047": "evidence",
      "1048": "justifies",
      "1049": "synthesis requires",
      "1050": "cycle through",
      "1051": "denatured by",
      "1052": "novel",
      "1053": "released in response to",
      "1054": "rising in",
      "1055": "may precipitate",
      "1056": "may suppress",
      "1057": "\u5835\u585e",
      "1058": "prescription",
      "1059": "structure contains",
      "1060": "prevented by",
      "1061": "improves",
      "1062": "are hallmark of",
      "1063": "biosynthetic precursor",
      "1064": "also known as",
      "1065": "may mask",
      "1066": "substitute for",
      "1067": "drug of choice",
      "1068": "may interfere",
      "1069": "developed as",
      "1070": "dilates",
      "1071": "neutralizes",
      "1072": "may enhance",
      "1073": "smooth",
      "1074": "is precursor to",
      "1075": "not recommended during",
      "1076": "fight",
      "1077": "diagnosed with",
      "1078": "required for",
      "1079": "artificially increases",
      "1080": "antagonizes",
      "1081": "depends",
      "1082": "classifies into",
      "1083": "symptoms include",
      "1084": "compound",
      "1085": "hinder",
      "1086": "excretion",
      "1087": "exclude",
      "1088": "bypass",
      "1089": "sold in",
      "1090": "avoid",
      "1091": "\u5982",
      "1092": "modulates",
      "1093": "control",
      "1094": "available in",
      "1095": "should be taken with",
      "1096": "established by",
      "1097": "\u4ee3\u8c22\u4e8e",
      "1098": "governs",
      "1099": "establish",
      "1100": "respond to",
      "1101": "monitoring requires",
      "1102": "\u907f\u514d",
      "1103": "more occlusive than",
      "1104": "may",
      "1105": "submitted by",
      "1106": "list",
      "1107": "can be managed by",
      "1108": "oral bioavailability",
      "1109": "screened via",
      "1110": "is resistant to",
      "1111": "provides prolonged",
      "1112": "overreacts to",
      "1113": "source of",
      "1114": "prevent",
      "1115": "examine",
      "1116": "resist",
      "1117": "can",
      "1118": "compare",
      "1119": "development history",
      "1120": "complications",
      "1121": "absorption enhanced by",
      "1122": "\u7ec4\u6210",
      "1123": "considered when",
      "1124": "overuse leads to",
      "1125": "synthetic version",
      "1126": "development",
      "1127": "\u662f",
      "1128": "\u7ef4\u6301",
      "1129": "alternative route",
      "1130": "are processed",
      "1131": "test",
      "1132": "marks the end",
      "1133": "application frequency",
      "1134": "are classified by",
      "1135": "is higher with",
      "1136": "essential for",
      "1137": "facilitates",
      "1138": "was an",
      "1139": "interactions",
      "1140": "major",
      "1141": "risk with",
      "1142": "protect against",
      "1143": "specializes in",
      "1144": "enabled by",
      "1145": "may be caused by",
      "1146": "is associated with",
      "1147": "progresses to",
      "1148": "\u7279\u5f81\u4e3a",
      "1149": "decreases with",
      "1150": "impaired by",
      "1151": "branches from",
      "1152": "can form",
      "1153": "remains",
      "1154": "low in",
      "1155": "principle",
      "1156": "should be stored at",
      "1157": "can be ingested",
      "1158": "pumps blood to",
      "1159": "mutated in",
      "1160": "transmitted via",
      "1161": "higher with",
      "1162": "prescription form",
      "1163": "reverses",
      "1164": "plays role",
      "1165": "toxicity",
      "1166": "oxidizes",
      "1167": "act in",
      "1168": "non-pharmacological treatment",
      "1169": "may develop",
      "1170": "carcinogenicity class",
      "1171": "activated during",
      "1172": "differ by",
      "1173": "require special",
      "1174": "has better",
      "1175": "can irritate",
      "1176": "key factor in",
      "1177": "assessed via",
      "1178": "processed into",
      "1179": "varies with",
      "1180": "processes",
      "1181": "more susceptible to",
      "1182": "come in",
      "1183": "absorption rate varies by",
      "1184": "compromised by",
      "1185": "combine",
      "1186": "marketed as",
      "1187": "viewed through",
      "1188": "is synthesized from",
      "1189": "discovered in",
      "1190": "barrier to",
      "1191": "must be",
      "1192": "shows",
      "1193": "branch into",
      "1194": "promoted by",
      "1195": "\u635f\u5bb3",
      "1196": "contributes",
      "1197": "may decrease",
      "1198": "mixed in",
      "1199": "are classified",
      "1200": "may change",
      "1201": "enter through",
      "1202": "compared with",
      "1203": "\u4f34\u6709",
      "1204": "characterized by",
      "1205": "recommended daily",
      "1206": "administer",
      "1207": "assists in",
      "1208": "obtained via",
      "1209": "degrade",
      "1210": "rises with",
      "1211": "is time for",
      "1212": "reported via",
      "1213": "\u9884\u9632\u901a\u8fc7",
      "1214": "have increased",
      "1215": "absorption inhibited by",
      "1216": "may disrupt",
      "1217": "applied to",
      "1218": "primary factor in",
      "1219": "excludes",
      "1220": "\u53ef\u80fd\u5f15\u8d77",
      "1221": "decrease",
      "1222": "\u8fd8\u5305\u62ec",
      "1223": "better treated with",
      "1224": "track",
      "1225": "gathered from",
      "1226": "administration errors",
      "1227": "are first-line treatment for",
      "1228": "detected via",
      "1229": "\u66ff\u4ee3",
      "1230": "observed in",
      "1231": "composition",
      "1232": "administered via",
      "1233": "shortens",
      "1234": "disputed by",
      "1235": "are prohibited in",
      "1236": "increases levels of",
      "1237": "starts working",
      "1238": "reduced in",
      "1239": "triggered by",
      "1240": "more effective",
      "1241": "systemic effects possible with",
      "1242": "lose",
      "1243": "goal of",
      "1244": "can be",
      "1245": "lower in",
      "1246": "generated by",
      "1247": "progress to",
      "1248": "limit",
      "1249": "aim",
      "1250": "deficiency common in",
      "1251": "injected by",
      "1252": "more susceptible",
      "1253": "storage form",
      "1254": "measured in",
      "1255": "function",
      "1256": "overuse causes",
      "1257": "may contraindicate",
      "1258": "varies",
      "1259": "research target",
      "1260": "constrict",
      "1261": "concern for",
      "1262": "nutrient",
      "1263": "are subclass of",
      "1264": "research topic",
      "1265": "incur",
      "1266": "affected by",
      "1267": "is prototype of",
      "1268": "distributed via",
      "1269": "recommended by",
      "1270": "off-label use",
      "1271": "\u8868\u73b0\u4e3a",
      "1272": "fluctuate during",
      "1273": "illustrate",
      "1274": "pathway inhibited by",
      "1275": "imbalance causes",
      "1276": "guidelines in",
      "1277": "minimize",
      "1278": "showed",
      "1279": "modeled via",
      "1280": "sometimes used for",
      "1281": "strengthen",
      "1282": "have reduced",
      "1283": "preferred",
      "1284": "\u76ee\u7684\u4e3a",
      "1285": "prescriber",
      "1286": "predict",
      "1287": "improves with",
      "1288": "newer option",
      "1289": "cause",
      "1290": "developed after",
      "1291": "incompatible with",
      "1292": "converted to",
      "1293": "operate",
      "1294": "tracked in",
      "1295": "growth",
      "1296": "can involve",
      "1297": "appears hyperintense on",
      "1298": "highlight",
      "1299": "detection window",
      "1300": "more expensive than",
      "1301": "protect",
      "1302": "accelerated by",
      "1303": "evaluated in",
      "1304": "misalignment",
      "1305": "normal range",
      "1306": "requires high-dose",
      "1307": "abused by",
      "1308": "communicate via",
      "1309": "threatens",
      "1310": "can degrade",
      "1311": "more sensitive than",
      "1312": "therapy",
      "1313": "processed in",
      "1314": "surrounded by",
      "1315": "carry",
      "1316": "solubility",
      "1317": "is common side effect of",
      "1318": "dormant form",
      "1319": "treatment success",
      "1320": "work",
      "1321": "progression",
      "1322": "\u5305\u62ec",
      "1323": "aims to",
      "1324": "identified by",
      "1325": "analyzed in",
      "1326": "feed",
      "1327": "is planned using",
      "1328": "should monitor",
      "1329": "reduced by",
      "1330": "convert to",
      "1331": "include",
      "1332": "synergizes with",
      "1333": "may necessitate",
      "1334": "combination products include",
      "1335": "conducted by",
      "1336": "remain",
      "1337": "increases effect of",
      "1338": "\u5173\u8054\u4e8e",
      "1339": "protects against",
      "1340": "have anti-inflammatory properties",
      "1341": "graded by",
      "1342": "not at risk",
      "1343": "discontinued via",
      "1344": "example",
      "1345": "are a type of",
      "1346": "collaborates with",
      "1347": "complicates",
      "1348": "combines with",
      "1349": "quality checked by",
      "1350": "classified as",
      "1351": "opposes",
      "1352": "chemical formula",
      "1353": "cushions",
      "1354": "common after",
      "1355": "metabolized via",
      "1356": "slowed by",
      "1357": "address",
      "1358": "\u8bca\u65ad\u901a\u8fc7",
      "1359": "decreases effectiveness of",
      "1360": "originate from",
      "1361": "higher risk of",
      "1362": "degrade under",
      "1363": "can impair",
      "1364": "tested via",
      "1365": "tapered to avoid",
      "1366": "allows",
      "1367": "classified into",
      "1368": "should be avoided before",
      "1369": "sometimes given",
      "1370": "autoimmune",
      "1371": "toxicity treated with",
      "1372": "toxicity increased by",
      "1373": "absorbed in",
      "1374": "fast-acting for",
      "1375": "\u6cbb\u7597\u76ee\u6807",
      "1376": "help with",
      "1377": "combination",
      "1378": "burns",
      "1379": "prioritized in",
      "1380": "FDA-approved for",
      "1381": "provided by",
      "1382": "stored as",
      "1383": "\u50a8\u5b58\u4e8e",
      "1384": "relieve",
      "1385": "penetrate tissues",
      "1386": "corrected by",
      "1387": "\u52a0\u91cd",
      "1388": "sometimes require",
      "1389": "employ",
      "1390": "add vasodilation to",
      "1391": "terminate in",
      "1392": "reacts to",
      "1393": "have more",
      "1394": "explain",
      "1395": "basis of",
      "1396": "more affordable",
      "1397": "can damage",
      "1398": "date to",
      "1399": "causes resistance to",
      "1400": "may damage",
      "1401": "visible in",
      "1402": "regulates",
      "1403": "gives",
      "1404": "require modified",
      "1405": "primarily prevents",
      "1406": "favorable for",
      "1407": "generic versions available for",
      "1408": "laboratory interactions",
      "1409": "absorbed through",
      "1410": "\u7814\u7a76\u7528\u4e8e",
      "1411": "timeframe",
      "1412": "convenient",
      "1413": "classify",
      "1414": "subclassified into",
      "1415": "allows for",
      "1416": "reported in",
      "1417": "overgrowth from",
      "1418": "evaluated through",
      "1419": "emphasizes",
      "1420": "changed by",
      "1421": "detects",
      "1422": "preventable by",
      "1423": "needed for",
      "1424": "osmolality",
      "1425": "rapidly restores",
      "1426": "may mutate",
      "1427": "first generation",
      "1428": "route of administration",
      "1429": "resistance",
      "1430": "visualizes",
      "1431": "occur during",
      "1432": "now include",
      "1433": "application",
      "1434": "\u53d7\u635f\u4e8e",
      "1435": "tracked via",
      "1436": "most common",
      "1437": "raises",
      "1438": "marked",
      "1439": "increases",
      "1440": "resistance in",
      "1441": "deficiency risk in",
      "1442": "warning",
      "1443": "penetrates",
      "1444": "compliance issues",
      "1445": "contracted by",
      "1446": "are typically",
      "1447": "more accessible than",
      "1448": "enforces",
      "1449": "\u63d0\u9ad8",
      "1450": "overexpressed in",
      "1451": "monitoring needed",
      "1452": "disposal requires",
      "1453": "quantify",
      "1454": "consists of",
      "1455": "compatible with",
      "1456": "cost-effectiveness",
      "1457": "vector for",
      "1458": "thiazide type",
      "1459": "possible with",
      "1460": "adsorption depends on",
      "1461": "diagnostic aid",
      "1462": "degenerates in",
      "1463": "cross blood-brain barrier",
      "1464": "resists",
      "1465": "reveal",
      "1466": "given by",
      "1467": "tracked during",
      "1468": "evolve",
      "1469": "have fewer",
      "1470": "manage",
      "1471": "assessment",
      "1472": "visible as",
      "1473": "combination with",
      "1474": "resistance prevalence",
      "1475": "misfolding causes",
      "1476": "can impact",
      "1477": "erode",
      "1478": "shorter with",
      "1479": "schedule",
      "1480": "interaction",
      "1481": "need lower",
      "1482": "hepatic adjustment",
      "1483": "may not protect",
      "1484": "\u6740\u706d",
      "1485": "absorption reduced by",
      "1486": "belongs to",
      "1487": "eliminates",
      "1488": "assist",
      "1489": "formed by",
      "1490": "easy to",
      "1491": "inform",
      "1492": "potency",
      "1493": "are risk of",
      "1494": "helps reduce",
      "1495": "regulate",
      "1496": "may need",
      "1497": "help regulate",
      "1498": "inserted in",
      "1499": "worsened by",
      "1500": "circulates in",
      "1501": "pierced by",
      "1502": "raise",
      "1503": "coats",
      "1504": "bind",
      "1505": "measured as",
      "1506": "cleared via",
      "1507": "involved in",
      "1508": "minimal with",
      "1509": "onset of action",
      "1510": "easier to apply than",
      "1511": "metabolized by",
      "1512": "can be caused by",
      "1513": "dictates",
      "1514": "cost depends on",
      "1515": "sought from",
      "1516": "applied as",
      "1517": "benefit",
      "1518": "obstructed by",
      "1519": "is typical",
      "1520": "associates with",
      "1521": "administration route",
      "1522": "damaged by",
      "1523": "comes in",
      "1524": "expel",
      "1525": "may support",
      "1526": "can be detected by",
      "1527": "reversed by",
      "1528": "rarely metastasizes",
      "1529": "travels through",
      "1530": "off-label uses",
      "1531": "has symptom",
      "1532": "do not spread",
      "1533": "\u8bc4\u4ef7\u6807\u51c6",
      "1534": "storage protection",
      "1535": "necessary for",
      "1536": "suit",
      "1537": "develops from",
      "1538": "originate in",
      "1539": "degrades",
      "1540": "declines",
      "1541": "metabolize drugs",
      "1542": "overdose risk",
      "1543": "should be avoided",
      "1544": "take",
      "1545": "achieved with",
      "1546": "deepen",
      "1547": "risk includes",
      "1548": "costs",
      "1549": "carries risk of",
      "1550": "clinical trial",
      "1551": "eliminated via",
      "1552": "provided in",
      "1553": "absent in",
      "1554": "is regulated by",
      "1555": "elevated in",
      "1556": "diminish",
      "1557": "is rare side effect of",
      "1558": "disrupted by",
      "1559": "more effective at",
      "1560": "side effect",
      "1561": "can alter",
      "1562": "may manifest as",
      "1563": "concerning in",
      "1564": "may result in",
      "1565": "converts",
      "1566": "dose",
      "1567": "published in",
      "1568": "transported via",
      "1569": "prescribed as",
      "1570": "is both",
      "1571": "granted after",
      "1572": "\u4e3b\u8981\u4e3a",
      "1573": "filled at",
      "1574": "key enzyme",
      "1575": "comparison",
      "1576": "can cause",
      "1577": "covered by",
      "1578": "persist in",
      "1579": "can replace",
      "1580": "can be used by",
      "1581": "brand",
      "1582": "topical forms",
      "1583": "collects",
      "1584": "restricts",
      "1585": "prioritizes",
      "1586": "partition coefficient affects",
      "1587": "prophylaxis use",
      "1588": "overdose symptom",
      "1589": "displaced in",
      "1590": "classified via",
      "1591": "may seek",
      "1592": "maintains",
      "1593": "geriatric use",
      "1594": "occurs during",
      "1595": "effectiveness",
      "1596": "treat",
      "1597": "adherence issues",
      "1598": "allows use in",
      "1599": "slow",
      "1600": "patent",
      "1601": "crucial in",
      "1602": "ranges from",
      "1603": "patent expiration",
      "1604": "OTC status",
      "1605": "often need",
      "1606": "expels",
      "1607": "may prevent",
      "1608": "research area",
      "1609": "\u5305\u542b",
      "1610": "recognized by",
      "1611": "compensate for",
      "1612": "approval",
      "1613": "clinical trials",
      "1614": "used off-label",
      "1615": "similar to",
      "1616": "historical use",
      "1617": "rely on",
      "1618": "symptoms of toxicity",
      "1619": "displacement reactions",
      "1620": "concerns",
      "1621": "advised",
      "1622": "complement",
      "1623": "help in",
      "1624": "\u4f5c\u7528\u673a\u5236",
      "1625": "disrupt",
      "1626": "\u5206\u4e3a",
      "1627": "withdrawal requires",
      "1628": "consider",
      "1629": "density",
      "1630": "association with",
      "1631": "arises from",
      "1632": "ratio",
      "1633": "combined with",
      "1634": "differs between",
      "1635": "help prevent",
      "1636": "works synergistically with",
      "1637": "avoid in",
      "1638": "optimize",
      "1639": "first-line for",
      "1640": "destroys",
      "1641": "help reduce",
      "1642": "is assessed",
      "1643": "symptom is",
      "1644": "changed regularly",
      "1645": "measures about",
      "1646": "identifies",
      "1647": "taken as",
      "1648": "coenzyme for",
      "1649": "spectrum",
      "1650": "result from",
      "1651": "chemical stability",
      "1652": "can transmit",
      "1653": "vehicle affects",
      "1654": "listed on",
      "1655": "\u5ef6\u7f13",
      "1656": "a type of",
      "1657": "ensure",
      "1658": "effect",
      "1659": "defends against",
      "1660": "risks",
      "1661": "is important",
      "1662": "is reduced by",
      "1663": "elevation",
      "1664": "pose",
      "1665": "are metabolized by",
      "1666": "taught in",
      "1667": "shield",
      "1668": "are applied",
      "1669": "dosage varies by",
      "1670": "develops",
      "1671": "is a",
      "1672": "first dose effect",
      "1673": "generic versions",
      "1674": "long-acting",
      "1675": "potential",
      "1676": "form",
      "1677": "ranges",
      "1678": "research focuses on",
      "1679": "develops resistance to",
      "1680": "offers",
      "1681": "\u8003\u8651",
      "1682": "are guided by",
      "1683": "funded by",
      "1684": "leaves",
      "1685": "matters for",
      "1686": "stability affected by",
      "1687": "\u5f62\u6210",
      "1688": "releases",
      "1689": "are used for",
      "1690": "may bind",
      "1691": "complication of",
      "1692": "loosen",
      "1693": "\u76d1\u6d4b\u901a\u8fc7",
      "1694": "aims",
      "1695": "achieve",
      "1696": "\u5bfc\u81f4",
      "1697": "applied via",
      "1698": "empowers",
      "1699": "function affects",
      "1700": "document",
      "1701": "aid",
      "1702": "differentiates",
      "1703": "transfers",
      "1704": "highest in",
      "1705": "form from",
      "1706": "may secrete",
      "1707": "attack",
      "1708": "building blocks of",
      "1709": "\u589e\u5f3a",
      "1710": "brand names include",
      "1711": "advise",
      "1712": "delays excretion of",
      "1713": "research studies",
      "1714": "encourage",
      "1715": "suitable for",
      "1716": "enhance effects of",
      "1717": "\u53ef\u80fd\u5f62\u6210",
      "1718": "impact",
      "1719": "dispense",
      "1720": "sterilized by",
      "1721": "may increase",
      "1722": "prescription required",
      "1723": "differ from",
      "1724": "do not affect",
      "1725": "production decreases with",
      "1726": "move",
      "1727": "reimbursed by",
      "1728": "receptor affinity",
      "1729": "\u8054\u5408\u4f7f\u7528",
      "1730": "shape",
      "1731": "help balance",
      "1732": "conduct",
      "1733": "can cross",
      "1734": "\u7528\u4e8e\u6cbb\u7597",
      "1735": "stage",
      "1736": "altered by",
      "1737": "administrated via",
      "1738": "may take",
      "1739": "disrupted in",
      "1740": "sometimes needs",
      "1741": "first approved",
      "1742": "manages",
      "1743": "improved by",
      "1744": "important",
      "1745": "listed in",
      "1746": "attacks",
      "1747": "support",
      "1748": "first-line",
      "1749": "can be perennial",
      "1750": "lactation caution",
      "1751": "combined in",
      "1752": "contributes to",
      "1753": "have elevated",
      "1754": "superior to",
      "1755": "may have reduced efficacy with",
      "1756": "recycles",
      "1757": "converted by",
      "1758": "may protect against",
      "1759": "harm",
      "1760": "often have",
      "1761": "nourish",
      "1762": "\u5177\u6709",
      "1763": "tracked by",
      "1764": "maximizes",
      "1765": "dry",
      "1766": "degraded by",
      "1767": "removes",
      "1768": "onset",
      "1769": "cofactor for",
      "1770": "increases risk of",
      "1771": "assessed in",
      "1772": "reported with",
      "1773": "instrument",
      "1774": "narrow",
      "1775": "worsens",
      "1776": "distributed by",
      "1777": "\u53ef\u80fd\u5bfc\u81f4",
      "1778": "prioritize",
      "1779": "protein-bound in",
      "1780": "inserted under",
      "1781": "\u5b58\u5728",
      "1782": "withdrawn due to",
      "1783": "appears at",
      "1784": "salt form",
      "1785": "sometimes help",
      "1786": "tolerance develops with",
      "1787": "peer-reviewed by",
      "1788": "measured before",
      "1789": "uses",
      "1790": "associated with",
      "1791": "subdivided into",
      "1792": "among",
      "1793": "can exacerbate",
      "1794": "controlled by",
      "1795": "prescription required for",
      "1796": "more common with",
      "1797": "requires monitoring of",
      "1798": "penetration",
      "1799": "phase",
      "1800": "sometimes contains",
      "1801": "validate",
      "1802": "may lead",
      "1803": "soothe",
      "1804": "patent expired",
      "1805": "map",
      "1806": "sometimes lacks",
      "1807": "can provide",
      "1808": "occur in",
      "1809": "accessed via",
      "1810": "\u57fa\u4e8e",
      "1811": "brand names",
      "1812": "screened for",
      "1813": "avoid with",
      "1814": "monitor",
      "1815": "is linked to",
      "1816": "second-line for",
      "1817": "\u51cf\u6162\u4e8e",
      "1818": "may be mitigated by",
      "1819": "synonym for",
      "1820": "also targets",
      "1821": "overdose causes",
      "1822": "\u53ef\u80fd\u4e0e",
      "1823": "receives input",
      "1824": "blocks",
      "1825": "released during",
      "1826": "cost varies by",
      "1827": "degradation product",
      "1828": "aggravated by",
      "1829": "biomarker for",
      "1830": "enable",
      "1831": "released by",
      "1832": "dilute",
      "1833": "dilutes",
      "1834": "aids",
      "1835": "typically",
      "1836": "indications",
      "1837": "at risk for",
      "1838": "discovered by",
      "1839": "challenge",
      "1840": "can aggravate",
      "1841": "first-line therapy for",
      "1842": "unsafe during",
      "1843": "metabolize",
      "1844": "more prone to",
      "1845": "validates",
      "1846": "found in",
      "1847": "is near",
      "1848": "\u5206\u7ea7\u4e8e",
      "1849": "administration method",
      "1850": "timing",
      "1851": "suggest",
      "1852": "may slow",
      "1853": "levels rise during",
      "1854": "emergency",
      "1855": "supply chain",
      "1856": "may originate from",
      "1857": "attached to",
      "1858": "administration",
      "1859": "lasts longer",
      "1860": "enzyme target",
      "1861": "restored by",
      "1862": "brand competition",
      "1863": "remove",
      "1864": "moisturize",
      "1865": "enhances",
      "1866": "effective against",
      "1867": "is based on",
      "1868": "evaluates",
      "1869": "can improve",
      "1870": "\u76d1\u6d4b",
      "1871": "milestone for",
      "1872": "performed using",
      "1873": "pharmacokinetics",
      "1874": "involved",
      "1875": "may alter",
      "1876": "ineffective in",
      "1877": "resorb",
      "1878": "reported for",
      "1879": "collected via",
      "1880": "aims for",
      "1881": "determined by",
      "1882": "education",
      "1883": "is active",
      "1884": "mechanism differs from",
      "1885": "most deadly",
      "1886": "can suppress",
      "1887": "available without",
      "1888": "was a",
      "1889": "enhanced by",
      "1890": "optimal for",
      "1891": "reduce",
      "1892": "absorption requires",
      "1893": "protein binding",
      "1894": "store at",
      "1895": "modify",
      "1896": "sensitize",
      "1897": "funding",
      "1898": "infected by",
      "1899": "\u5bf9",
      "1900": "can predict",
      "1901": "effective for",
      "1902": "achieved via",
      "1903": "preferred by",
      "1904": "helps prevent",
      "1905": "researched by",
      "1906": "inhibits",
      "1907": "not a",
      "1908": "must comply",
      "1909": "dispenses",
      "1910": "impedes",
      "1911": "levels increase during",
      "1912": "displaces",
      "1913": "estimates",
      "1914": "check for",
      "1915": "teratogenicity",
      "1916": "neutralized by",
      "1917": "created using",
      "1918": "rehabilitation",
      "1919": "subclass",
      "1920": "identified through",
      "1921": "delivered by",
      "1922": "compares",
      "1923": "competes with",
      "1924": "synthesis",
      "1925": "mitigated with",
      "1926": "treatment",
      "1927": "used with caution with",
      "1928": "may form",
      "1929": "completed by",
      "1930": "\u9884\u9632",
      "1931": "often has",
      "1932": "absorption decreases with",
      "1933": "adjust for",
      "1934": "hydrates",
      "1935": "secretion follows",
      "1936": "assess",
      "1937": "broken down by",
      "1938": "adherence tool",
      "1939": "often prescribed with",
      "1940": "combated by",
      "1941": "symptoms",
      "1942": "disadvantage",
      "1943": "accumulate in",
      "1944": "modulate",
      "1945": "declines with",
      "1946": "preparation",
      "1947": "assessment tool",
      "1948": "prolong",
      "1949": "investigated for",
      "1950": "\u4e2a\u4f53\u5dee\u5f02",
      "1951": "optimized for",
      "1952": "may trigger",
      "1953": "taken by",
      "1954": "detect",
      "1955": "high risk of",
      "1956": "animal models use",
      "1957": "appears on",
      "1958": "reserved for",
      "1959": "are studied via",
      "1960": "limited to",
      "1961": "recommended dose",
      "1962": "promote",
      "1963": "corrects",
      "1964": "designed for",
      "1965": "bioequivalence",
      "1966": "begins at",
      "1967": "\u8bc4\u4f30\u901a\u8fc7",
      "1968": "monitor closely",
      "1969": "alternative treatments",
      "1970": "are studied in",
      "1971": "is evaluated in",
      "1972": "monitoring includes",
      "1973": "may ease",
      "1974": "diagnose",
      "1975": "directs",
      "1976": "often high in",
      "1977": "exhibit",
      "1978": "history",
      "1979": "mediate",
      "1980": "supplement",
      "1981": "exfoliates",
      "1982": "used with",
      "1983": "calculation",
      "1984": "important in",
      "1985": "diagnosis",
      "1986": "concentration in",
      "1987": "\u907f\u514d\u4e0e",
      "1988": "mediated by",
      "1989": "recommends",
      "1990": "tests",
      "1991": "inform about",
      "1992": "oversees",
      "1993": "have less",
      "1994": "\u8868\u73b0\u5305\u62ec",
      "1995": "comes from",
      "1996": "may regenerate",
      "1997": "absorption site",
      "1998": "phases",
      "1999": "reduce absorption of",
      "2000": "signals to",
      "2001": "prevalence increases",
      "2002": "aggravate",
      "2003": "synthesizes",
      "2004": "utilizes",
      "2005": "originates from",
      "2006": "systemic effects",
      "2007": "moves",
      "2008": "calm",
      "2009": "synthetic form is",
      "2010": "alternatives to",
      "2011": "prescription requires",
      "2012": "used it for",
      "2013": "metabolizes",
      "2014": "applied by",
      "2015": "is an",
      "2016": "dependent on",
      "2017": "is",
      "2018": "not for",
      "2019": "OTC availability",
      "2020": "alters",
      "2021": "propel",
      "2022": "common",
      "2023": "tests for",
      "2024": "requires",
      "2025": "predisposes to",
      "2026": "ECG effect",
      "2027": "\u4f7f\u7528",
      "2028": "is needed for",
      "2029": "transmit",
      "2030": "receives input from",
      "2031": "follow-up",
      "2032": "type of",
      "2033": "feedback inhibits",
      "2034": "weakened in",
      "2035": "can metastasize",
      "2036": "drives",
      "2037": "initiated before",
      "2038": "often caused by",
      "2039": "excretion unchanged",
      "2040": "form in",
      "2041": "checked via",
      "2042": "association",
      "2043": "awarded by",
      "2044": "balance",
      "2045": "primary goal of",
      "2046": "is best for",
      "2047": "precursor for",
      "2048": "phosphorylates",
      "2049": "recognize",
      "2050": "train",
      "2051": "\u7981\u5fcc\u4e8e",
      "2052": "invaded by",
      "2053": "risks include",
      "2054": "mitigate",
      "2055": "stockage",
      "2056": "reproduce by",
      "2057": "categorized in",
      "2058": "indicate",
      "2059": "originally developed for",
      "2060": "relaxes",
      "2061": "cautioned about",
      "2062": "discontinuation protocol",
      "2063": "helps manage",
      "2064": "can trigger",
      "2065": "labeled with",
      "2066": "may interact",
      "2067": "specialization",
      "2068": "\u6cbb\u7597\u5305\u62ec",
      "2069": "guides",
      "2070": "increases risk",
      "2071": "enterohepatic recirculation",
      "2072": "comprise",
      "2073": "basis for",
      "2074": "research conducted by",
      "2075": "result",
      "2076": "unclog",
      "2077": "may become",
      "2078": "decreases absorption",
      "2079": "consult",
      "2080": "treatment duration",
      "2081": "protects",
      "2082": "evaluated by",
      "2083": "acidifies",
      "2084": "antagonist",
      "2085": "genetic",
      "2086": "prone to",
      "2087": "characteristic",
      "2088": "digested in",
      "2089": "distribution affected by",
      "2090": "function measured by",
      "2091": "\u7528\u4e8e",
      "2092": "have",
      "2093": "adequacy",
      "2094": "vary in",
      "2095": "active form of",
      "2096": "collected from",
      "2097": "often includes",
      "2098": "inspect",
      "2099": "supported by",
      "2100": "achieved by",
      "2101": "displace",
      "2102": "invest in",
      "2103": "less side effects",
      "2104": "is disclosed in",
      "2105": "guided by",
      "2106": "compete with",
      "2107": "is extended-spectrum",
      "2108": "results in",
      "2109": "can contraindicate",
      "2110": "\u68c0\u6d4b\u4e8e",
      "2111": "are a subclass of",
      "2112": "contraindication",
      "2113": "must be ruled out",
      "2114": "habitat",
      "2115": "exfoliate",
      "2116": "treated with",
      "2117": "distribution volume",
      "2118": "supervised by",
      "2119": "assesses",
      "2120": "patented in",
      "2121": "combat",
      "2122": "balanced against",
      "2123": "protected by",
      "2124": "hijacked by",
      "2125": "predicts",
      "2126": "activate",
      "2127": "availability",
      "2128": "may clog",
      "2129": "uncommon with",
      "2130": "sometimes use",
      "2131": "tolerate",
      "2132": "enzymes break down",
      "2133": "is unit of",
      "2134": "are preferred in",
      "2135": "benign",
      "2136": "performed via",
      "2137": "measures",
      "2138": "often requires",
      "2139": "monitored during",
      "2140": "perform",
      "2141": "prescribed based",
      "2142": "specialized",
      "2143": "\u6539\u53d8",
      "2144": "helps in",
      "2145": "requires dose adjustment of",
      "2146": "cytokine involved",
      "2147": "reviewed during",
      "2148": "depletes with",
      "2149": "taken",
      "2150": "processed by",
      "2151": "derived from",
      "2152": "scheduled via",
      "2153": "\u9776\u5411",
      "2154": "precaution",
      "2155": "\u53ef\u80fd\u8fdb\u5c55\u4e3a",
      "2156": "broader than",
      "2157": "demonstrate",
      "2158": "climate favors",
      "2159": "life cycle includes",
      "2160": "major protein of",
      "2161": "often used by",
      "2162": "\u53ef\u80fd\u6709",
      "2163": "revolutionized",
      "2164": "connects to",
      "2165": "is the",
      "2166": "blocked by",
      "2167": "worsens with",
      "2168": "organizes drugs by",
      "2169": "adjunct in",
      "2170": "adherence important",
      "2171": "restored with",
      "2172": "review",
      "2173": "can fail",
      "2174": "recalled due to",
      "2175": "activates",
      "2176": "\u4f9d\u8d56",
      "2177": "teach",
      "2178": "relates to",
      "2179": "pumps",
      "2180": "boosts",
      "2181": "can regulate",
      "2182": "effectiveness decreases",
      "2183": "passes",
      "2184": "potentiates",
      "2185": "inhabit",
      "2186": "is often",
      "2187": "coordinates",
      "2188": "monitoring needed for",
      "2189": "statistical power",
      "2190": "consist of",
      "2191": "accesses",
      "2192": "onset time",
      "2193": "work in",
      "2194": "more common in",
      "2195": "cheaper than",
      "2196": "myelinated by",
      "2197": "adjuvant use",
      "2198": "refers to",
      "2199": "temporary",
      "2200": "regulatory approval",
      "2201": "antidote",
      "2202": "potentiate",
      "2203": "not effective for",
      "2204": "help build",
      "2205": "dysfunction linked to",
      "2206": "life-threatening condition",
      "2207": "minimizes",
      "2208": "increase risk of",
      "2209": "shortage",
      "2210": "may irritate",
      "2211": "reviewed by",
      "2212": "often combined",
      "2213": "managed by",
      "2214": "does not prevent",
      "2215": "infection",
      "2216": "considered",
      "2217": "constricts",
      "2218": "followed by",
      "2219": "\u4e0e",
      "2220": "diagnostic test",
      "2221": "cost factor",
      "2222": "located below",
      "2223": "present in",
      "2224": "advise on",
      "2225": "worn by",
      "2226": "can absorb",
      "2227": "adjusted based on",
      "2228": "classified under",
      "2229": "sprayed on",
      "2230": "examples",
      "2231": "adjusts",
      "2232": "high in",
      "2233": "tolerance develops",
      "2234": "prescribed with",
      "2235": "future developments",
      "2236": "soothes",
      "2237": "dispensed in",
      "2238": "are targets of",
      "2239": "weakened by",
      "2240": "toxic at",
      "2241": "may show",
      "2242": "administered as",
      "2243": "preserves",
      "2244": "inflammation of",
      "2245": "research",
      "2246": "acts on",
      "2247": "can relieve",
      "2248": "type",
      "2249": "pH",
      "2250": "are found in",
      "2251": "pose risk of",
      "2252": "patient monitoring",
      "2253": "may involve",
      "2254": "numbs",
      "2255": "result in",
      "2256": "fights",
      "2257": "risk in",
      "2258": "build",
      "2259": "symptom",
      "2260": "should be spaced apart from",
      "2261": "especially important with",
      "2262": "is delayed by",
      "2263": "is approved for",
      "2264": "destroy",
      "2265": "benefits from",
      "2266": "main ingredient",
      "2267": "applied",
      "2268": "synergizes",
      "2269": "biomarker",
      "2270": "excreted through",
      "2271": "number varies",
      "2272": "depletes",
      "2273": "should not be",
      "2274": "printed on",
      "2275": "quality of life improves with",
      "2276": "is used for",
      "2277": "considerations",
      "2278": "tone",
      "2279": "increase risk",
      "2280": "inversely related",
      "2281": "\u5438\u5f15",
      "2282": "worsen",
      "2283": "may prolong",
      "2284": "primarily lower",
      "2285": "is a sign of",
      "2286": "levels indicate",
      "2287": "global need",
      "2288": "have lower cross-reactivity with",
      "2289": "therapeutic index",
      "2290": "can boost",
      "2291": "formulated as",
      "2292": "harms",
      "2293": "\u8bc4\u4f30",
      "2294": "rich in",
      "2295": "adherence",
      "2296": "thresholds vary by",
      "2297": "\u53ef\u5bfc\u81f4",
      "2298": "consumed by",
      "2299": "may deplete",
      "2300": "increases demand for",
      "2301": "account for",
      "2302": "delays",
      "2303": "severity depends on",
      "2304": "supplements",
      "2305": "is part of",
      "2306": "\u5728",
      "2307": "employs",
      "2308": "lasts for",
      "2309": "affects",
      "2310": "may impair",
      "2311": "set by",
      "2312": "influenced by",
      "2313": "peak effect",
      "2314": "participant",
      "2315": "work best with",
      "2316": "examined for",
      "2317": "masks",
      "2318": "can be contacted",
      "2319": "trade names",
      "2320": "\u5b9a\u4e49\u4e3a",
      "2321": "has narrow",
      "2322": "historic use",
      "2323": "drooping",
      "2324": "interact with",
      "2325": "\u8bc4\u4f30\u4e8e",
      "2326": "has different",
      "2327": "discovery year",
      "2328": "adjusted for",
      "2329": "fills",
      "2330": "contrast with",
      "2331": "despite",
      "2332": "makes",
      "2333": "\u4ea7\u751f",
      "2334": "pharmacophore",
      "2335": "develops over",
      "2336": "alleviates",
      "2337": "is influenced by",
      "2338": "act on",
      "2339": "\u91ca\u653e",
      "2340": "enter",
      "2341": "removed by",
      "2342": "updates",
      "2343": "quantifies",
      "2344": "may preserve",
      "2345": "second generation",
      "2346": "given",
      "2347": "ATC code",
      "2348": "prevalence",
      "2349": "worse in",
      "2350": "show time-dependent",
      "2351": "have immature",
      "2352": "\u4e0d\u9002\u7528\u4e8e",
      "2353": "indicates",
      "2354": "prompts",
      "2355": "restricted in",
      "2356": "adjunct to",
      "2357": "differential diagnosis",
      "2358": "available as",
      "2359": "absorption decreased by",
      "2360": "is affected by",
      "2361": "side effect of",
      "2362": "delayed by",
      "2363": "examples include",
      "2364": "is selective",
      "2365": "wears",
      "2366": "resistance caused by",
      "2367": "\u53ef\u80fd\u9884\u6d4b",
      "2368": "binds tightly to",
      "2369": "trained in",
      "2370": "evaluates by",
      "2371": "heal",
      "2372": "sometimes combined",
      "2373": "frequency of administration",
      "2374": "located in",
      "2375": "may experience",
      "2376": "less expensive than",
      "2377": "can still",
      "2378": "not for use on",
      "2379": "sequenced for",
      "2380": "claimed by",
      "2381": "targets",
      "2382": "thicken during",
      "2383": "could reduce",
      "2384": "duration depends on",
      "2385": "decrease during",
      "2386": "aim for",
      "2387": "synthesis involves",
      "2388": "distribution",
      "2389": "breakdown",
      "2390": "discovered through",
      "2391": "patent status",
      "2392": "don't reduce",
      "2393": "dialysis",
      "2394": "implanted in",
      "2395": "temporary solution",
      "2396": "supplies",
      "2397": "come as",
      "2398": "located on",
      "2399": "filters",
      "2400": "a sign of",
      "2401": "\u8c03\u8282",
      "2402": "release",
      "2403": "good for",
      "2404": "can enhance",
      "2405": "increase",
      "2406": "applies",
      "2407": "found on",
      "2408": "withdrawn gradually",
      "2409": "hazardous to",
      "2410": "component of",
      "2411": "can be seasonal",
      "2412": "toxicity symptom",
      "2413": "produced from",
      "2414": "generic version",
      "2415": "graded",
      "2416": "higher in",
      "2417": "dietary source",
      "2418": "should include",
      "2419": "eliminate",
      "2420": "spreads through",
      "2421": "conflicts with",
      "2422": "resolves",
      "2423": "subtypes include",
      "2424": "missed dose",
      "2425": "\u5f02\u5e38\u4e8e",
      "2426": "purchased by",
      "2427": "frequently need",
      "2428": "develops after",
      "2429": "show",
      "2430": "contained by",
      "2431": "achieved through",
      "2432": "wrote",
      "2433": "helps with",
      "2434": "\u91cd\u8981\u5bf9\u4e8e",
      "2435": "receive",
      "2436": "is reversible with",
      "2437": "indicated by",
      "2438": "holds",
      "2439": "potential use",
      "2440": "set",
      "2441": "has alternatives",
      "2442": "converted from",
      "2443": "mechanism similarity",
      "2444": "impaired in",
      "2445": "are building blocks of",
      "2446": "advantage",
      "2447": "has types",
      "2448": "caution",
      "2449": "supplement form",
      "2450": "may replace",
      "2451": "introduced in",
      "2452": "led to",
      "2453": "also acts as",
      "2454": "solution",
      "2455": "aims at",
      "2456": "historically called",
      "2457": "are type of",
      "2458": "complements",
      "2459": "levels peak at",
      "2460": "seek",
      "2461": "preferred over",
      "2462": "\u6e90\u4e8e",
      "2463": "is obtained from",
      "2464": "may occur due to",
      "2465": "inflames",
      "2466": "empirical therapy",
      "2467": "repels",
      "2468": "types",
      "2469": "alter",
      "2470": "is essential for",
      "2471": "excreted",
      "2472": "digested into",
      "2473": "hydrate",
      "2474": "defend against",
      "2475": "sets",
      "2476": "elimination",
      "2477": "discourages",
      "2478": "management",
      "2479": "stockpiled for",
      "2480": "not recommended for",
      "2481": "option for",
      "2482": "occurs between",
      "2483": "administrated as",
      "2484": "may appear",
      "2485": "lack",
      "2486": "may cause",
      "2487": "addresses",
      "2488": "enriched with",
      "2489": "WHO essential medicine",
      "2490": "weakens",
      "2491": "not recommended with",
      "2492": "dissolves",
      "2493": "helps identify",
      "2494": "differs from",
      "2495": "can alleviate",
      "2496": "susceptible to",
      "2497": "adjusted in",
      "2498": "mask",
      "2499": "extracted from",
      "2500": "generates",
      "2501": "convert",
      "2502": "street name",
      "2503": "break down",
      "2504": "work at",
      "2505": "traps",
      "2506": "researched for",
      "2507": "accessed by",
      "2508": "damage",
      "2509": "prepared by",
      "2510": "WHO guideline",
      "2511": "guideline",
      "2512": "recycled via",
      "2513": "research in",
      "2514": "diagnoses",
      "2515": "legal status",
      "2516": "is diagnosed",
      "2517": "facilitated by",
      "2518": "interpreted by",
      "2519": "avoided in",
      "2520": "commonly supplemented in",
      "2521": "component",
      "2522": "may interfere with",
      "2523": "decreases risk of",
      "2524": "\u6d4b\u91cf",
      "2525": "assist in",
      "2526": "means",
      "2527": "can aid",
      "2528": "metabolized into",
      "2529": "OTC available for",
      "2530": "may coexist with",
      "2531": "\u9632\u6b62",
      "2532": "not suitable for",
      "2533": "stops",
      "2534": "protect from",
      "2535": "free of",
      "2536": "innervate",
      "2537": "part of",
      "2538": "powers",
      "2539": "countered by",
      "2540": "stability in",
      "2541": "tracks",
      "2542": "governed by",
      "2543": "may worsen",
      "2544": "types include",
      "2545": "divided into",
      "2546": "prevents",
      "2547": "can interact with",
      "2548": "confined to",
      "2549": "has type",
      "2550": "magnify",
      "2551": "receive adjusted doses",
      "2552": "research focus",
      "2553": "withdrawal",
      "2554": "drug class",
      "2555": "stored in",
      "2556": "publish in",
      "2557": "\u9884\u6d4b",
      "2558": "stains",
      "2559": "symptom relief",
      "2560": "is altered in",
      "2561": "comorbid with",
      "2562": "can include",
      "2563": "used for",
      "2564": "often require",
      "2565": "appear as",
      "2566": "lazy eye",
      "2567": "clear",
      "2568": "complication",
      "2569": "also available",
      "2570": "target of",
      "2571": "terminates",
      "2572": "initiates",
      "2573": "oversee",
      "2574": "strive for",
      "2575": "cross",
      "2576": "specifies",
      "2577": "share structure with",
      "2578": "less effective for",
      "2579": "known as",
      "2580": "\u523a\u6fc0",
      "2581": "advances",
      "2582": "diagnosed by",
      "2583": "prolongation",
      "2584": "personalize",
      "2585": "\u76d1\u6d4b\u4e8e",
      "2586": "should be",
      "2587": "repositions",
      "2588": "degraded in",
      "2589": "thrive in",
      "2590": "is under",
      "2591": "constrict due to",
      "2592": "evaluated using",
      "2593": "may vary in",
      "2594": "is a symptom",
      "2595": "suggests",
      "2596": "prescriber specialty",
      "2597": "emulsify",
      "2598": "at risk of",
      "2599": "extend",
      "2600": "marketed for",
      "2601": "black box warning",
      "2602": "shows increasing",
      "2603": "can be improved by",
      "2604": "spread",
      "2605": "\u5e38\u4f34\u6709",
      "2606": "\u529f\u80fd\u8bc4\u4f30\u7528",
      "2607": "prescribed for",
      "2608": "extends",
      "2609": "approved",
      "2610": "produced as",
      "2611": "may react to",
      "2612": "vulnerable to",
      "2613": "cross placenta",
      "2614": "marketed by",
      "2615": "not applied to",
      "2616": "monitoring parameter",
      "2617": "\u4fdd\u62a4",
      "2618": "passes into",
      "2619": "can result from",
      "2620": "\u5931\u5e38\u4e8e",
      "2621": "contraindicated for",
      "2622": "determines",
      "2623": "lipid solubility",
      "2624": "asymptomatic in",
      "2625": "risk factor",
      "2626": "toxicity symptoms",
      "2627": "synthesized as",
      "2628": "provide long-term",
      "2629": "may suggest",
      "2630": "delivers drug through",
      "2631": "check",
      "2632": "depression",
      "2633": "essential",
      "2634": "also available as",
      "2635": "obstructs",
      "2636": "occurs in",
      "2637": "ranked by",
      "2638": "describes",
      "2639": "evaluated via",
      "2640": "elevates",
      "2641": "future direction",
      "2642": "bypasses",
      "2643": "tool for",
      "2644": "strengthens",
      "2645": "detectable in",
      "2646": "effective in",
      "2647": "consume",
      "2648": "monitored with",
      "2649": "evaluated",
      "2650": "valuable for",
      "2651": "timing matters",
      "2652": "covers",
      "2653": "recommended intake",
      "2654": "volume of distribution",
      "2655": "not evaluated by",
      "2656": "not effective",
      "2657": "secreted in",
      "2658": "swelling indicates",
      "2659": "fourth generation",
      "2660": "met by",
      "2661": "hypothesized via",
      "2662": "may develop into",
      "2663": "\u6291\u5236",
      "2664": "can prevent",
      "2665": "acts in",
      "2666": "\u53ef\u80fd\u7531",
      "2667": "guidelines",
      "2668": "repurposed for",
      "2669": "\u5173\u8054",
      "2670": "operated by",
      "2671": "linked to",
      "2672": "\u53ef\u80fd\u5f71\u54cd",
      "2673": "\u7814\u53d1\u6d89\u53ca",
      "2674": "indicator",
      "2675": "lactation safety",
      "2676": "increases likelihood",
      "2677": "seen on",
      "2678": "interacts",
      "2679": "require",
      "2680": "work on",
      "2681": "reverse with",
      "2682": "reactivation causes",
      "2683": "antagonized by",
      "2684": "may use",
      "2685": "undergoes",
      "2686": "secreted during",
      "2687": "lubricate",
      "2688": "may regulate",
      "2689": "may lead to",
      "2690": "recommended daily intake",
      "2691": "are used in",
      "2692": "speed up",
      "2693": "adverse events",
      "2694": "deliver to",
      "2695": "paired with",
      "2696": "staged by",
      "2697": "chemical class",
      "2698": "prefer",
      "2699": "toxicity affects",
      "2700": "crucial for",
      "2701": "primarily excreted",
      "2702": "returns to",
      "2703": "less potent than",
      "2704": "global burden",
      "2705": "mechanism of",
      "2706": "compete in",
      "2707": "attracts",
      "2708": "is antidote for",
      "2709": "often take",
      "2710": "predicted by",
      "2711": "approves",
      "2712": "relate to",
      "2713": "screening",
      "2714": "\u7ed9\u836f\u9014\u5f84",
      "2715": "receptor binding",
      "2716": "synergy",
      "2717": "travel via",
      "2718": "has side effect",
      "2719": "marker",
      "2720": "side effects include",
      "2721": "medication",
      "2722": "comprises",
      "2723": "must follow",
      "2724": "chemical structure",
      "2725": "discontinued for",
      "2726": "RELATIONSHIP",
      "2727": "may result from",
      "2728": "is a general term for",
      "2729": "used alongside",
      "2730": "applied on",
      "2731": "increases requirement for",
      "2732": "namesake",
      "2733": "not used for",
      "2734": "resistance genes",
      "2735": "disorder",
      "2736": "research use",
      "2737": "are absorbed in",
      "2738": "less side effects than",
      "2739": "resistance mechanism",
      "2740": "tailors",
      "2741": "purchased as",
      "2742": "have different",
      "2743": "acute phase reactant",
      "2744": "used postoperatively",
      "2745": "\u53cd\u6620",
      "2746": "critical for",
      "2747": "contain",
      "2748": "oral administration of",
      "2749": "depend on",
      "2750": "generic",
      "2751": "amplify",
      "2752": "may alleviate",
      "2753": "evaluated for",
      "2754": "should combine with",
      "2755": "performed for",
      "2756": "included in",
      "2757": "are subject to",
      "2758": "decreases risk",
      "2759": "limited in",
      "2760": "most common type",
      "2761": "endemic for",
      "2762": "maintained by",
      "2763": "metabolized",
      "2764": "generic available",
      "2765": "destroyed by",
      "2766": "screened with",
      "2767": "stewardship",
      "2768": "personalized via",
      "2769": "prevented via",
      "2770": "packaging",
      "2771": "restore",
      "2772": "maximum dose",
      "2773": "overuse",
      "2774": "verified through",
      "2775": "is synthetic",
      "2776": "administration technique",
      "2777": "duration varies by",
      "2778": "\u8f85\u52a9",
      "2779": "can induce",
      "2780": "needed in",
      "2781": "applied before",
      "2782": "can be separated",
      "2783": "thickens",
      "2784": "counteract",
      "2785": "easier for",
      "2786": "inflammation",
      "2787": "can lead to",
      "2788": "metabolite",
      "2789": "veterinary use",
      "2790": "severity",
      "2791": "increases inflammation",
      "2792": "a subtype of",
      "2793": "inactivated in",
      "2794": "secrete",
      "2795": "evaluation",
      "2796": "may lower",
      "2797": "dosage adjustment",
      "2798": "safer than",
      "2799": "has risk of",
      "2800": "develops with",
      "2801": "cost-effective for",
      "2802": "mix with",
      "2803": "measured via",
      "2804": "may interact with",
      "2805": "lower",
      "2806": "regulated more strictly",
      "2807": "deficiency",
      "2808": "breaks down",
      "2809": "exist in",
      "2810": "\u75c7\u72b6\u5305\u62ec",
      "2811": "filtered by",
      "2812": "threat to",
      "2813": "contraindicate",
      "2814": "increased by",
      "2815": "\u53d6\u51b3\u4e8e",
      "2816": "composed of",
      "2817": "may potentiate",
      "2818": "\u8bc6\u522b",
      "2819": "sold as",
      "2820": "are affected by",
      "2821": "\u4f5c\u7528\u4e8e",
      "2822": "damaged in",
      "2823": "collaborate on",
      "2824": "future",
      "2825": "soften",
      "2826": "opsonize",
      "2827": "typically is",
      "2828": "checked before",
      "2829": "leads",
      "2830": "calculated by",
      "2831": "can detoxify",
      "2832": "issue",
      "2833": "approve",
      "2834": "\u786e\u4fdd",
      "2835": "commonly treated with",
      "2836": "used with caution",
      "2837": "well tolerated in",
      "2838": "minimized by",
      "2839": "lasts under",
      "2840": "sometimes available",
      "2841": "class includes",
      "2842": "mutates",
      "2843": "antagonistic with",
      "2844": "storage requires",
      "2845": "also treat",
      "2846": "supports",
      "2847": "hepatic impairment",
      "2848": "has long",
      "2849": "research focus on",
      "2850": "deposit in",
      "2851": "desensitizes",
      "2852": "are detected by",
      "2853": "mechanism",
      "2854": "hallmark of",
      "2855": "drains",
      "2856": "a side effect of",
      "2857": "monitoring",
      "2858": "ensured by",
      "2859": "shed in",
      "2860": "production",
      "2861": "prescription needed",
      "2862": "visible under",
      "2863": "patient counseling",
      "2864": "link",
      "2865": "suppresses",
      "2866": "adverse effect",
      "2867": "developed through",
      "2868": "peak during",
      "2869": "need",
      "2870": "\u6307\u5bfc",
      "2871": "exchanges",
      "2872": "\u8bc4\u4f30\u7528",
      "2873": "shelf life",
      "2874": "has risks",
      "2875": "active metabolites",
      "2876": "decays to",
      "2877": "genetic variation",
      "2878": "topical use",
      "2879": "occur with",
      "2880": "can deplete",
      "2881": "must pass",
      "2882": "should not be used",
      "2883": "attract",
      "2884": "could be",
      "2885": "achieves",
      "2886": "commonly spreads to",
      "2887": "marker for",
      "2888": "manufactured by",
      "2889": "emits",
      "2890": "effect altered by",
      "2891": "broader class",
      "2892": "drug interactions",
      "2893": "used off-label for",
      "2894": "measured by",
      "2895": "lack in",
      "2896": "accessible",
      "2897": "is more",
      "2898": "creates",
      "2899": "forces out",
      "2900": "should block",
      "2901": "line",
      "2902": "name",
      "2903": "achieved for",
      "2904": "controls for",
      "2905": "transports",
      "2906": "cover",
      "2907": "block",
      "2908": "mechanism of action",
      "2909": "demonstrated in",
      "2910": "clogs",
      "2911": "is in",
      "2912": "precursor of",
      "2913": "transport",
      "2914": "investigated by",
      "2915": "corrected with",
      "2916": "monitoring required for",
      "2917": "used in",
      "2918": "diagnosed via",
      "2919": "controls",
      "2920": "bioavailability",
      "2921": "stimulate",
      "2922": "manufacturing requires",
      "2923": "need reduced",
      "2924": "\u836f\u6548\u5b66",
      "2925": "causes fluorosis at",
      "2926": "crosses BBB",
      "2927": "levels vary with",
      "2928": "poorly absorbed",
      "2929": "not mixed with",
      "2930": "deter",
      "2931": "manifests as",
      "2932": "subset of",
      "2933": "reduces absorption of",
      "2934": "hepatic dose adjustment",
      "2935": "sometimes replace",
      "2936": "read by",
      "2937": "may include",
      "2938": "analyzed by",
      "2939": "trigger",
      "2940": "at higher risk",
      "2941": "\u5e38\u89c1\u4e8e",
      "2942": "inserted into",
      "2943": "enters breast milk",
      "2944": "can be managed",
      "2945": "reflects",
      "2946": "colorants",
      "2947": "necessitates",
      "2948": "measure",
      "2949": "deficiency causes",
      "2950": "amplifies",
      "2951": "kills",
      "2952": "resistance marker",
      "2953": "less commonly used",
      "2954": "design",
      "2955": "lower risk of",
      "2956": "purpose",
      "2957": "has risk",
      "2958": "less commonly used than",
      "2959": "specify",
      "2960": "prescribed post",
      "2961": "transport protein",
      "2962": "catalyzes",
      "2963": "temperature",
      "2964": "\u51cf\u5c11",
      "2965": "are effective against",
      "2966": "duration of action",
      "2967": "contraindication for",
      "2968": "carry risk of",
      "2969": "safety",
      "2970": "prescribing trends show",
      "2971": "receptor target",
      "2972": "monitored in",
      "2973": "absorption varies by",
      "2974": "gold standard",
      "2975": "heal faster with",
      "2976": "expiration",
      "2977": "require no",
      "2978": "common in",
      "2979": "combats",
      "2980": "development involves",
      "2981": "replaced by",
      "2982": "cleared by",
      "2983": "accelerate",
      "2984": "role",
      "2985": "metabolism",
      "2986": "distribution involves",
      "2987": "metabolized in",
      "2988": "polymer of",
      "2989": "precedes",
      "2990": "specializes",
      "2991": "alternative treatment",
      "2992": "attaches to",
      "2993": "alleviate",
      "2994": "abused as",
      "2995": "potency determined by",
      "2996": "\u88ab\u6291\u5236\u5bfc\u81f4",
      "2997": "environmental risk",
      "2998": "modified by",
      "2999": "regenerate via",
      "3000": "offer",
      "3001": "such as",
      "3002": "detected in",
      "3003": "leads to",
      "3004": "research ongoing for",
      "3005": "neutral effect on",
      "3006": "modifies",
      "3007": "transforms",
      "3008": "synthesized by",
      "3009": "implemented by",
      "3010": "material",
      "3011": "softens",
      "3012": "overdosed",
      "3013": "may target",
      "3014": "guideline recommendation",
      "3015": "weaker than",
      "3016": "contracts",
      "3017": "repair",
      "3018": "has effect",
      "3019": "underlie",
      "3020": "cleanse",
      "3021": "are reported to",
      "3022": "belong to",
      "3023": "customized for",
      "3024": "are researched for",
      "3025": "lowers",
      "3026": "presented by",
      "3027": "is when",
      "3028": "implicated in",
      "3029": "site of",
      "3030": "specialist in",
      "3031": "responds to",
      "3032": "minimal for",
      "3033": "is used in",
      "3034": "called",
      "3035": "does not block",
      "3036": "less effective in",
      "3037": "conducted in",
      "3038": "helps",
      "3039": "correlates",
      "3040": "monitored through",
      "3041": "work via",
      "3042": "heals around",
      "3043": "treatment for",
      "3044": "adverse effects correlate with",
      "3045": "withdrawal symptom",
      "3046": "adapt to",
      "3047": "enters",
      "3048": "compensates",
      "3049": "hospital use",
      "3050": "studies",
      "3051": "needs",
      "3052": "is important for",
      "3053": "dosed by",
      "3054": "often needs",
      "3055": "from",
      "3056": "enforced by",
      "3057": "absorption affected by",
      "3058": "comparative efficacy",
      "3059": "dosage depends on",
      "3060": "occurs due to",
      "3061": "first-line treatment",
      "3062": "may reduce",
      "3063": "circulate in",
      "3064": "manufacturer",
      "3065": "increase indicates",
      "3066": "required by",
      "3067": "\u901a\u5e38",
      "3068": "vary by",
      "3069": "alternative",
      "3070": "thins",
      "3071": "may require",
      "3072": "differentiate into",
      "3073": "suppress",
      "3074": "genetic regulation",
      "3075": "rarely cause",
      "3076": "stronger than",
      "3077": "influences",
      "3078": "issued by",
      "3079": "detected with",
      "3080": "prevented with",
      "3081": "role in",
      "3082": "cool",
      "3083": "expiration date",
      "3084": "utilize",
      "3085": "excretion route",
      "3086": "can increase",
      "3087": "analyzes",
      "3088": "meta-analysis shows",
      "3089": "renal adjustment",
      "3090": "may help with",
      "3091": "results from",
      "3092": "rebound phenomenon occurs after",
      "3093": "relies on",
      "3094": "category includes",
      "3095": "often susceptible to",
      "3096": "\u53ef\u4ee5",
      "3097": "can be mixed",
      "3098": "due to",
      "3099": "helps regulate",
      "3100": "laboratory interference",
      "3101": "standardize",
      "3102": "dosed",
      "3103": "treatment for toxicity",
      "3104": "evaluate",
      "3105": "is called",
      "3106": "worked on",
      "3107": "may affect",
      "3108": "works best at",
      "3109": "produce",
      "3110": "mediator",
      "3111": "sometimes cause",
      "3112": "incorporate",
      "3113": "loosens",
      "3114": "researched in",
      "3115": "obtained at",
      "3116": "can provoke",
      "3117": "fertilizes",
      "3118": "reflect",
      "3119": "store",
      "3120": "helps evaluate",
      "3121": "antagonize",
      "3122": "emit",
      "3123": "other class",
      "3124": "helps cope with",
      "3125": "alternative approach",
      "3126": "cloud",
      "3127": "indicator of",
      "3128": "caution in",
      "3129": "converts to",
      "3130": "examples are",
      "3131": "excretion half-life",
      "3132": "\u53d7",
      "3133": "deposits",
      "3134": "comorbidity",
      "3135": "\u5408\u6210\u9700\u8981",
      "3136": "boost",
      "3137": "\u6392\u6cc4\u4e8e",
      "3138": "scheduled by",
      "3139": "may exclude",
      "3140": "can spread",
      "3141": "vital for",
      "3142": "collaborate with",
      "3143": "\u63a7\u5236",
      "3144": "involve",
      "3145": "approach",
      "3146": "follows",
      "3147": "stability",
      "3148": "infect",
      "3149": "distributes",
      "3150": "delay",
      "3151": "peaks at",
      "3152": "dysregulated in",
      "3153": "deliver",
      "3154": "\u4ee3\u8868\u836f\u7269",
      "3155": "aids in",
      "3156": "prepares for",
      "3157": "improve",
      "3158": "administration timing",
      "3159": "techniques include"
}